Interestingly, an in vitro model has shown that chemotherapy increased LAG-3 expression, which makes combining novel immune checkpoint inhibitors with conventional chemotherapy promising in difficult-to-treat cancers such as VHs [11]. Here, LAG3 is linked to cancer.